Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

Share Price is delayed by 15 minutes
Get Live Data
4,948.00    4.00 (0.08%)
Bid:
4,956.00
Ask:
4,964.00
Spread: 8.00 (0.161%)
Market Cap: £2.31b
MGNS Live PriceLast checked at - London Stock Exchange

Intraday Morgan Sindall Group Share Chart

Directorship Changes

23 Nov 2023 07:00

RNS Number : 3776U
Morgan Sindall Group PLC
23 November 2023
 
Morgan Sindall Group plc

 

23 November 2023

 

Directorship changes

 

 

Morgan Sindall Group plc announces that Tracey Killen has notified the Board of her intention to step down as a non-executive director with effect from 31 December 2023. Jen Tippin will take over from Tracey as chair of the remuneration committee with effect from 7 December 2023.

 

Sharon Fennessy will join the Board as a non-executive director, with effect from 1 January 2024. Sharon will be a member of the nomination and audit committees and will take over as audit committee chair after the AGM in 2024.

 

Sharon is a highly accomplished FTSE financial leader with a strong track record of reporting standards at the highest level. She is currently non-executive director and member of the remuneration committee at Gowan Group Limited and non-executive director member of the audit and risk committee at John Lewis Partnership Limited. Sharon has strong strategic and commercial experience developed through her career at Diageo plc and in roles with Nortel Networks and Deloitte. 

 

Commenting on the changes, Michael Findlay, Chair of Morgan Sindall Group plc, said:

 

"I'd like to thank Tracey for her significant contribution to the Board over the last six years and wish her all the best for the future. I am delighted to welcome Sharon to the Board and look forward to working with her. Sharon brings extensive financial experience and strategic and commercial skills which will further broaden the expertise on the Board, adding valuable knowledge and insight to our discussions."

 

Ends

 

Notes to Editors:

There are no other details requiring disclosure under Listing Rule 9.6.13 in relation to Sharon Rolston

 

Morgan Sindall Group plc is a leading UK Construction & Regeneration group with annual revenue of £3.6bn, employing around 7,600 employees and operating in the public, regulated and private sectors. It reports through six divisions of Construction, Infrastructure, Fit Out, Property Services, Partnership Housing and Urban Regeneration.

 

 

ENQUIRIES:

 

Morgan Sindall Group plc

Tel: 020 7307 9200

Michael Findlay, Chair

 

 

 

Brunswick

Tel: 020 7404 5959

 

Jonathan Glass

Nina Coad

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPGUGGUPWGMP
Date   Source Headline
8th May 20147:00 amRNSAGM and Q1 Interim Management Statement
30th Apr 20149:17 amRNSTotal Voting Rights
3rd Apr 20148:48 amRNSDirector/PDMR Shareholding
26th Mar 20148:30 amRNSAnnual Financial Report
19th Mar 20144:54 pmRNSHolding(s) in Company
18th Mar 20145:02 pmRNSBlocklisting Interim Review
17th Mar 20143:31 pmRNSDirector/PDMR Shareholding
27th Feb 20144:47 pmRNSTotal Voting Rights
18th Feb 20147:00 amRNSFinal Results
31st Jan 201412:23 pmRNSTotal Voting Rights
23rd Dec 20134:12 pmRNSTotal Voting Rights
13th Dec 20137:00 amRNSBoard Change
29th Nov 20134:26 pmRNSTotal Voting Rights
7th Nov 20137:00 amRNSInterim Management Statement
31st Oct 20132:18 pmRNSTotal Voting Rights
9th Oct 20134:41 pmRNSHolding(s) in Company
30th Sep 20134:48 pmRNSTotal Voting Rights
27th Sep 20131:22 pmRNSDirector/PDMR Shareholding
25th Sep 20135:01 pmRNSHolding(s) in Company
17th Sep 201310:06 amRNSHolding(s) in Company
30th Aug 20133:51 pmRNSTotal Voting Rights
13th Aug 20134:41 pmRNSHolding(s) in Company
13th Aug 201312:04 pmRNS£100m South Shields Regeneration Project
12th Aug 201311:47 amRNSNotifications of Major Interests in Shares
9th Aug 20131:11 pmRNSDirector/PDMR Shareholding
9th Aug 201312:00 pmRNSHolding(s) in Company
5th Aug 20137:00 amRNSHalf Yearly Report
31st Jul 20133:08 pmRNSTotal Voting Rights
11th Jul 20137:00 amRNS£269m Woolwich Redevelopment Programme Award
2nd Jul 20139:23 amRNSDirector Declaration
28th Jun 20132:45 pmRNSTotal Voting Rights
28th Jun 20137:19 amRNSDisposal of PFI interest
26th Jun 20134:17 pmRNSHolding(s) in Company
11th Jun 201310:30 amRNSHolding(s) in Company
31st May 201311:45 amRNSTotal Voting Rights
30th May 20138:11 amRNSBlocklisting Interim Review
24th May 20139:30 amRNSHolding(s) in Company
9th May 20131:53 pmRNSResult of AGM
9th May 20137:00 amRNSAGM and Q1 Interim Management Statement
7th May 20139:00 amRNSMuse Developments appointed preferred bidder
30th Apr 20131:53 pmRNSTotal Voting Rights
16th Apr 20137:00 amRNSLovell signs £63.3m Dagenham homes scheme
8th Apr 201310:12 amRNSHolding(s) in Company
2nd Apr 20139:45 amRNSHolding(s) in Company
28th Mar 20135:22 pmRNSHolding(s) in Company
28th Mar 20133:04 pmRNSTotal Voting Rights
26th Mar 20133:36 pmRNSAnnual Financial Report
20th Mar 20135:36 pmRNSDirector/PDMR Shareholding
15th Mar 20133:39 pmRNSHolding(s) in Company
13th Mar 20135:18 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.